Published in Proc Natl Acad Sci U S A on March 01, 1980
GTP-binding domain: three consensus sequence elements with distinct spacing. Proc Natl Acad Sci U S A (1987) 5.16
Escherichia coli ribosomes translate in vivo with variable rate. EMBO J (1984) 4.39
The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J (1994) 4.36
A novel GTP-binding protein, Sar1p, is involved in transport from the endoplasmic reticulum to the Golgi apparatus. J Cell Biol (1989) 4.29
Transcription from efficient promoters can interfere with plasmid replication and diminish expression of plasmid specified genes. EMBO J (1982) 4.26
Mutational analysis of SEC4 suggests a cyclical mechanism for the regulation of vesicular traffic. EMBO J (1989) 3.70
Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83
Polypeptide chain elongation factor 1 alpha (EF-1 alpha) from yeast: nucleotide sequence of one of the two genes for EF-1 alpha from Saccharomyces cerevisiae. EMBO J (1984) 2.77
Molecular cloning and sequence analysis of a ras gene from Schizosaccharomyces pombe. EMBO J (1985) 2.63
Molecular cloning and sequence determination of the nuclear gene coding for mitochondrial elongation factor Tu of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1983) 2.33
Nucleotide sequence of a Euglena gracilis chloroplast genome region coding for the elongation factor Tu; evidence for a spliced mRNA. Nucleic Acids Res (1983) 2.15
A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells. EMBO J (1989) 1.97
Homologies in the primary structure of GTP-binding proteins: the nucleotide-binding site of EF-Tu and p21. EMBO J (1984) 1.88
Dual function transcripts specifying tRNA and mRNA. Nature (1981) 1.85
The serC-aro A operon of Escherichia coli. A mixed function operon encoding enzymes from two different amino acid biosynthetic pathways. Biochem J (1986) 1.75
Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64
Biochemical properties of the ras-related YPT protein in yeast: a mutational analysis. EMBO J (1987) 1.61
Methylation of elongation factor 1 alpha from the fungus Mucor. Proc Natl Acad Sci U S A (1982) 1.30
Evolution of translational elongation factor (EF) sequences: reliability of global phylogenies inferred from EF-1 alpha(Tu) and EF-2(G) proteins. Proc Natl Acad Sci U S A (1994) 1.26
Specific peptide-activated proteolytic cleavage of Escherichia coli elongation factor Tu. Proc Natl Acad Sci U S A (1998) 1.20
Mutations in the Escherichia coli UvrB ATPase motif compromise excision repair capacity. Proc Natl Acad Sci U S A (1989) 1.16
Translation elongation factor Tu cleaved by a phage-exclusion system. Proc Natl Acad Sci U S A (1994) 1.07
Role of the 5'-terminal phosphate of tRNA for its function during protein biosynthesis elongation cycle. Nucleic Acids Res (1980) 1.04
Shotgun proteomics of the haloarchaeon Haloferax volcanii. J Proteome Res (2008) 1.02
Interaction of Mycobacterium tuberculosis elongation factor Tu with GTP is regulated by phosphorylation. J Bacteriol (2011) 1.00
The elongation factor Tu.kirromycin complex has two binding sites for tRNA molecules. EMBO J (1982) 0.99
Evidence for an internal promoter preceding tufA in the str operon of Escherichia coli. J Bacteriol (1982) 0.95
Functional implications related to the gene structure of the elongation factor EF-Tu from Halobacterium marismortui. Nucleic Acids Res (1990) 0.95
Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structure. EMBO J (1984) 0.93
N-terminal protein processing: a comparative proteogenomic analysis. Mol Cell Proteomics (2012) 0.92
Oversynthesis of elongation factors G and Tu in Escherichia coli. J Bacteriol (1982) 0.86
Two tuf genes in the cyanobacterium Spirulina platensis. J Bacteriol (1984) 0.86
Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria. Biopolymers (2008) 0.82
Genetic and molecular analysis of the tRNA-tufB operon of the myxobacterium Stigmatella aurantiaca. Nucleic Acids Res (1995) 0.82
42Sp48 in previtellogenic Xenopus oocytes is structurally homologous to EF-1 alpha and may be a stage-specific elongation factor. J Cell Biol (1991) 0.80
Mycoplasma and bacterial proteins resembling contractile proteins: a review. Yale J Biol Med (1984) 0.80
Estimation of deuteration levels in whole cells and cellular proteins by 1H n.m.r. spectroscopy and neutron scattering. Biochem J (1981) 0.79
Strength and Regulation of Seven rRNA Promoters in Escherichia coli. PLoS One (2015) 0.77
Precursor for elongation factor Tu from Escherichia coli. J Bacteriol (1986) 0.75
Selenite Reduction by Anaerobic Microbial Aggregates: Microbial Community Structure, and Proteins Associated to the Produced Selenium Spheres. Front Microbiol (2016) 0.75
Large-scale analysis of post-translational modifications in E. coli under glucose-limiting conditions. BMC Genomics (2017) 0.75
Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol (1978) 29.77
Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry (1974) 12.07
Identification of two copies of the gene for the elongation factor EF-Tu in E. coli. Nature (1975) 5.70
Genetics of bacterial ribosomes. Annu Rev Genet (1977) 5.64
Amino-terminal sequence analysis of proteins purified on a nanomole scale by gel electrophoresis. J Biol Chem (1972) 5.24
The role of guanosine 5'-triphosphate in polypeptide chain elongation. Biochim Biophys Acta (1978) 5.02
Protein biosynthesis. Annu Rev Biochem (1971) 5.00
RNA replication: function and structure of Qbeta-replicase. Annu Rev Biochem (1979) 4.42
Studies on polypeptide elongation factors from Escherichia coli. II. Purification of factors Tu-guanosine diphosphate, Ts, and Tu-Ts, and crystallization of Tu-guanosine diphosphate and Tu-Ts. J Biol Chem (1972) 2.22
Solid-phase Edman degradation. An automatic peptide sequencer. Eur J Biochem (1971) 2.14
Studies on the purification and properties of factor Tu from E. coli. Arch Biochem Biophys (1970) 2.02
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Determination of the amino acid sequence of the monkey, sheep, and dog proinsulin C-peptides by a semi-micro Edman degradation procedure. J Biol Chem (1972) 1.62
Determination of the complete amino acid sequence of bovine cardiac troponin C. Biochemistry (1976) 1.47
ATP binding to a protease-resistant core of actin. Proc Natl Acad Sci U S A (1976) 1.42
Elongation factor Tu and the aminoacyl-tRNA-EFTu-GTP complex. Methods Enzymol (1974) 1.36
Sequence analysis of fluorescamine-stained peptides and proteins purified on a nanomole scale. Application to proteins of bacteriophage MS2. Eur J Biochem (1974) 1.33
Direct demonstration of duplicate tuf genes in enteric bacteria. Proc Natl Acad Sci U S A (1978) 1.29
High resolution x-ray crystallographic analysis of a modified form of the elongation factor Tu: guanosine diphosphate complex. J Mol Biol (1978) 1.26
The reactions of the sulfhydryl groups on the elongation factors Tu and Ts. Arch Biochem Biophys (1971) 1.21
The elongation factor Tu coded by the tufA gene of Escherichia coli K-12 is almost identical to that coded by the tufB gene. J Biol Chem (1977) 1.19
Studies on the polypeptide elongation factors form E. coli. VI. Characterization of sulfhydryl groups in EF-Tu and EF-Ts. J Biochem (1974) 1.17
Does a bacterial elongation factor share a common evolutionary ancestor with actin? J Supramol Struct (1976) 1.05
Coupling techniques in solid-phase sequencing. Methods Enzymol (1977) 1.02
In vivo methylation of prokaryotic elongation factor Tu. J Biol Chem (1979) 1.02
Letters to the editor: Nuclear magnetic resonance studies of protein-RNA interactions. I. The elongation factor Tu-GTP aminoacyl-tRNA complex. J Mol Biol (1974) 1.01
Location of the site of methylation in elongation factor Tu. FEBS Lett (1979) 0.98
Conformational alteration of protein synthesis elongation factor EF-Tu by EF-Ts and by kirromycin. Proc Natl Acad Sci U S A (1977) 0.98
A comparison of the activities of the products of the two genes for elongation factor Tu. Mol Gen Genet (1978) 0.95
Limited hydrolysis of the polypeptide chain elongation factor Tu by trypsin. Isolation and characterization of the polypeptide fragments. J Biochem (1976) 0.94
Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA. Proc Natl Acad Sci U S A (1978) 0.92
The evolution of elongation factors Tu and G by gene duplication. FEBS Lett (1978) 0.92
Amino acid sequence of elongation factor Tu. Sequence of a region containing the thiol group essential for GTP binding. FEBS Lett (1975) 0.90
Studies on the polypeptide elongation factors from E. coli. 3. Molecular characteristics of EF-Tu-guanosine diphosphate, EP-Ts, and EF-Tu-Ts complex. J Biochem (1973) 0.88
Alignment of the tryptic fragments and location of sulfhydryl groups of the polypeptide chain elongation factor Tu. Biochem Biophys Res Commun (1977) 0.87
Guanosine triphosphate and guanosine diphosphate as conformation-determining molecules. Differential interaction of a fluorescent probe with the guanosine nucleotide complexes of bacterial elongation factor Tu. Biochemistry (1974) 0.86
Magnetic resonance studies of the manganese guanosine di- and triphosphate complexes with elongation factor Tu. J Biol Chem (1977) 0.86
Purification and properties of a new polypeptide chain elongation factor, EF-1beta, from pig liver. J Biol Chem (1976) 0.84
The primary structure of elongation factor G from Escherichia coli. Amino acid sequence of the region containing the GTP-binding center. FEBS Lett (1978) 0.84
Crystals of a large tryptic peptide (fragment A) of elongation factor EF-Tu from Escherichia coli. FEBS Lett (1977) 0.83
Amino acid sequence of elongation factor Tu. Characterization and alignment of the cyanogen bromide fragments and location of the cysteine residues. FEBS Lett (1977) 0.83
Structural fluctuation of the polypeptide-chain elongation factor Tu. A comparison of factors from Escherichia coli and Thermus thermophilus HB8. Eur J Biochem (1977) 0.82
Preliminary x-ray diffraction data for tetragonal crystals of trypsinized Escherichia coli elongation factor. J Mol Biol (1977) 0.81
Involvement of histidine residues in the substrate binding of elongation factor Tu from Thermus thermophilus: proton nuclear magnetic resonance and photooxidation study. Arch Biochem Biophys (1979) 0.81
Amino acid sequences of two sulfhydryl-containing tryptic peptides of the polypeptide chain elongation factor Tu. Biochem Biophys Res Commun (1975) 0.80
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
The optimization principle in phylogenetic analysis tends to give incorrect topologies when the number of nucleotides or amino acids used is small. Proc Natl Acad Sci U S A (1998) 15.43
A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A (1988) 11.81
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Simultaneous identification of bacterial virulence genes by negative selection. Science (1995) 10.52
Structure of yeast phenylalanine tRNA at 3 A resolution. Nature (1974) 10.27
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties. Antimicrob Agents Chemother (1975) 8.67
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Pipemidic acid: its activities against various experimental infections. Antimicrob Agents Chemother (1976) 7.92
Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature (1986) 7.73
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog. Science (1995) 7.39
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Surface density of calcium ions and calcium spikes in the barnacle muscle fiber membrane. J Gen Physiol (1967) 6.59
The anomalous rectification and cation selectivity of the membrane of a starfish egg cell. J Membr Biol (1974) 6.43
Pipemidic acid: absorption, distribution, and excretion. Antimicrob Agents Chemother (1975) 6.38
Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet (1988) 6.30
E-CELL: software environment for whole-cell simulation. Bioinformatics (1999) 6.29
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother (1991) 6.19
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J Biol Chem (1989) 5.09
The role of guanosine 5'-triphosphate in polypeptide chain elongation. Biochim Biophys Acta (1978) 5.02
Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science (1985) 5.00
Requirement of stereospecific alignments for initiation from the simian virus 40 early promoter. Nature (1986) 4.77
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
Regulation of DNA-replication origins during cell-cycle progression. Nature (1998) 4.52
GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction. Cell (1987) 4.50
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun (1993) 4.32
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell (2001) 4.24
The nucleotide sequence of the cloned tufA gene of Escherichia coli. Gene (1980) 4.17
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 3.96
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation (1995) 3.82
Epidemiology of the Hong Kong-68 variant of influenza A2 in Britain. Br Med J (1971) 3.74
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis (1998) 3.69
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65
Role of a ras homolog in the life cycle of Schizosaccharomyces pombe. Cell (1986) 3.54
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Inflammatory pseudotumors of the lung. Ann Thorac Surg (1999) 3.51
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Post-tetanic hyperpolarization and electrogenic Na pump in stretch receptor neurone of crayfish. J Physiol (1966) 3.42
Variant of penicillinase mediated by an R factor in Escherichia coli. J Bacteriol (1970) 3.33
Efficient promoter cassettes for enhanced expression of foreign genes in dicotyledonous and monocotyledonous plants. Plant Cell Physiol (1996) 3.30
Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J Bacteriol (1984) 3.27
Poliomyelitis surveillance in England and Wales, 1965-8. Public Health (1970) 3.25
Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate. J Bacteriol (1968) 3.22
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
Facilities and diagnostic criteria in sexually transmitted disease clinics in England and Wales. Br J Vener Dis (1978) 3.21
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Electric-field-induced superconductivity in an insulator. Nat Mater (2008) 3.17
The role of N-formyl-methionyl-sRNA in protein biosynthesis. J Mol Biol (1966) 3.16
Lobar torsion after pulmonary resection: presentation and outcome. J Thorac Cardiovasc Surg (2001) 3.16
Structural details of the binding of guanosine diphosphate to elongation factor Tu from E. coli as studied by X-ray crystallography. EMBO J (1985) 3.14
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. Antimicrob Agents Chemother (1978) 3.12
S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell (1990) 3.09
Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol (1993) 3.08
Evolutionary motif and its biological and structural significance. J Mol Evol (1997) 3.03
Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol (2000) 2.96
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
Mis6, a fission yeast inner centromere protein, acts during G1/S and forms specialized chromatin required for equal segregation. Cell (1997) 2.88
The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A (1999) 2.87
Discrepancies in immunization records. Community Med (1980) 2.85
Attendance at a London casualty department. J R Coll Gen Pract (1977) 2.84
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1996) 2.84
cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol (2000) 2.83
Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83
Specific protein binding to the simian virus 40 enhancer in vitro. Mol Cell Biol (1986) 2.82
Nucleotide sequence of N-formyl-methionyl-transfer RNA. Nature (1968) 2.82
Bni1p and Bnr1p: downstream targets of the Rho family small G-proteins which interact with profilin and regulate actin cytoskeleton in Saccharomyces cerevisiae. EMBO J (1997) 2.80
Polypeptide chain elongation factor 1 alpha (EF-1 alpha) from yeast: nucleotide sequence of one of the two genes for EF-1 alpha from Saccharomyces cerevisiae. EMBO J (1984) 2.77
Atomic Control of the SrTiO3 Crystal Surface. Science (1994) 2.72
Isolation of Rickettsia tsutsugamushi antigenically different from Kato, Karp, and Gilliam strains from patients. Microbiol Immunol (1984) 2.70
The reaction of phenylglyoxal with arginine residues in proteins. J Biol Chem (1968) 2.67
Calcium and potassium currents of the membrane of a barnacle muscle fibre in relation to the calcium spike. J Physiol (1969) 2.63
Molecular cloning and sequence analysis of a ras gene from Schizosaccharomyces pombe. EMBO J (1985) 2.63
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int (2007) 2.61
A model for the tertiary structure of p21, the product of the ras oncogene. Science (1985) 2.61
Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol (1989) 2.58
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys. Antimicrob Agents Chemother (1983) 2.58
Completeness of statutory notification for acute bacterial meningitis. Br Med J (1976) 2.58
C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A (1994) 2.57
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci U S A (1988) 2.55
Isolation of a second yeast Saccharomyces cerevisiae gene (GPA2) coding for guanine nucleotide-binding regulatory protein: studies on its structure and possible functions. Proc Natl Acad Sci U S A (1988) 2.54
Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol (1996) 2.49
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Unique primed start of phage phi X174 DNA replication and mobility of the primosome in a direction opposite chain synthesis. Proc Natl Acad Sci U S A (1981) 2.44
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42